ArticleJournal of clinical medicine2020

Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression.

Jennifer M Enright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.